Amisulpride and Brintellix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amisulpride (amisulpride) and Brintellix (vortioxetine hydrobromide). Common drug interactions include toxic epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Amisulpride and Brintellix. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Brintellix?

Brintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 6,749 Brintellix users. Check the latest studies of Brintellix.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

12 people who take Amisulpride and Brintellix together, and have interactions are studied.

Amisulpride and Brintellix drug interactions.

What are the common drug interactions of Amisulpride and Brintellix, by gender? *:

female:

n/a

male:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Vertigo
  4. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Asthenia (weakness)
  7. Confusional state
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

What are the common drug interactions of Amisulpride and Brintellix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Vertigo
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Confusional state

50-59:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

What are the existing conditions these people have? *

  1. Urinary Tract Infection: 3 people, 25.00%
  2. Stress And Anxiety: 2 people, 16.67%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 16.67%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 16.67%
  5. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 16.67%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%
  7. Psychotic Disorder: 1 person, 8.33%
  8. Migraine (headache): 1 person, 8.33%
  9. Lung Cancer - Small Cell (lung cancer): 1 person, 8.33%
  10. Insomnia (sleeplessness): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and Brintellix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amisulpride and Brintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amisulpride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride and vortioxetine hydrobromide (the active ingredients of Amisulpride and Brintellix, respectively), and Amisulpride and Brintellix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: